Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 975 of 994 entries
View as:

A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02096666 Org: User:
Start: 04/15/14 End: 12/07/18 Due: 12/07/19

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

Phase: N/A Priority: Normal
NCT ID: NCT02567370 Org: User:
Start: 08/31/15 End: 10/31/15 Due: 10/31/16

A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06352892 Org: User:
Start: 04/25/24 End: 08/27/24 Due: 08/27/25

Study of AMG 256 in Adult Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04362748 Org: User:
Start: 09/15/20 End: 09/21/23 Due: 09/21/24

Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00117234 Org: User:
Start: 09/30/02 End: 07/31/04 Due: 07/31/05

A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01199289 Org: User:
Start: 10/04/10 End: 12/21/11 Due: 12/21/12

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT02279173 Org: User:
Start: 12/10/14 End: 08/08/19 Due: 08/08/20

Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03029234 Org: User:
Start: 03/31/17 End: 06/04/21 Due: 06/04/22

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01137552 Org: User:
Start: 06/30/10 End: 04/30/14 Due: 04/30/15

A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04163991 Org: User:
Start: 12/09/19 End: 12/28/21 Due: 12/28/22

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00460265 Org: User:
Start: 05/31/07 End: 05/31/12 Due: 05/31/13

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00034346 Org: User:
Start: 01/31/02 End: - Due: -

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT00117624 Org: User:
Start: 12/31/02 End: 12/31/03 Due: 12/31/04

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00606450 Org: User:
Start: 04/01/06 End: 05/01/07 Due: 05/01/08

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00144131 Org: User:
Start: 08/31/05 End: - Due: -

Chemotherapy Related Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00035607 Org: User:
Start: 12/31/01 End: 04/30/03 Due: 04/30/04

Study of Haemodialysis Patients Switching From Aranesp to Biosimilar

Phase: N/A Priority: Normal
NCT ID: NCT02191150 Org: User:
Start: 06/30/14 End: 05/31/15 Due: 05/31/16

A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416

Phase: N/A Priority: Normal
NCT ID: NCT03283098 Org: User:
Start: 03/01/18 End: 02/04/19 Due: 02/04/20

A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT02637141 Org: User:
Start: 04/13/16 End: 03/14/17 Due: 03/14/18

AMG 386 Drug-Drug Interaction Study With Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT01992341 Org: User:
Start: 07/31/12 End: 09/30/14 Due: 09/30/15

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Phase: N/A Priority: Normal
NCT ID: NCT01327612 Org: User:
Start: 03/03/11 End: 02/05/20 Due: 02/05/21

A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02626793 Org: User:
Start: 08/03/15 End: 06/14/18 Due: 06/14/19

Study To Assess FRacTure Healing With SclerosTin Antibody - Hip

Phase: N/A Priority: Normal
NCT ID: NCT01081678 Org: User:
Start: 06/20/10 End: 05/10/13 Due: 05/10/14

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00239239 Org: User:
Start: 08/31/05 End: 03/31/07 Due: 03/31/08

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00332163 Org: User:
Start: 04/30/06 End: 09/30/08 Due: 09/30/09